Clinical Trial Update: Oral Calcitriol With Ketoconazole in CRPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral calcitriol with ketoconazole in castration-resistant prostate cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Donald Trump, MD | Conditions: Castration-resistant Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-02-08